Author Archives: BioRisk Association of the Philippines 2015, Inc.

In BRAPs commitment to the goals and ideals of the International Federation of Biosafety Association, we post here verbatim the letter of its Executive Director Ms. Maureen Ellis. Dear Colleagues, We would like to draw your attention to the recently … Continue reading →

Many in-house and commercial assays that detect the COVID-19 virus have been developed or are currently under development. Many of these molecular assays are currently being validated in partner laboratories. An overview of assays that have applied to FIND for participation in … Continue reading →

WHO has established a shipment mechanism to expedite and cover the costs of the shipment of clinical samples from patients with suspected COVID-19 from the country of collection to one of the WHO reference laboratories providing confirmatory molecular testing for COVID-19. This document explains … Continue reading →